ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,118,523 | +7.9% | 174,277 | +0.0% | 0.49% | +19.5% |
| Q2 2023 | $9,381,277 | -36.7% | 174,276 | -53.3% | 0.41% | -42.3% |
| Q1 2023 | $14,831,686 | -16.8% | 373,406 | -15.8% | 0.71% | -17.5% |
| Q4 2022 | $17,831,384 | +21.5% | 443,236 | -3.0% | 0.86% | +13.9% |
| Q3 2022 | $14,680,000 | +8.5% | 456,748 | +0.2% | 0.76% | +8.9% |
| Q2 2022 | $13,526,000 | +35.9% | 455,880 | +28.8% | 0.70% | +83.4% |
| Q1 2022 | $9,952,000 | +160.4% | 354,045 | +326.8% | 0.38% | +168.8% |
| Q4 2021 | $3,822,000 | +17.1% | 82,944 | -28.1% | 0.14% | -27.3% |
| Q3 2014 | $3,265,000 | -16.3% | 115,440 | +1.9% | 0.19% | -11.8% |
| Q2 2014 | $3,902,000 | +72.8% | 113,290 | +57.3% | 0.22% | +73.2% |
| Q1 2014 | $2,258,000 | – | 72,020 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |